| Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers LJ Trevena, BJ Zikmund-Fisher, A Edwards, W Gaissmaier, M Galesic, ... BMC medical informatics and decision making 13 (2), 1-15, 2013 | 493 | 2013 |
| Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters G Elwyn, PJ Barr, SW Grande, R Thompson, T Walsh, EM Ozanne Patient education and counseling 93 (1), 102-107, 2013 | 294 | 2013 |
| The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process PJ Barr, R Thompson, T Walsh, SW Grande, EM Ozanne, G Elwyn Journal of medical Internet research 16 (1), e3085, 2014 | 248 | 2014 |
| An approach to measuring the quality of breast cancer decisions K Sepucha, E Ozanne, K Silvia, A Partridge, AG Mulley Jr Patient education and counseling 65 (2), 261-269, 2007 | 170 | 2007 |
| Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients D Braithwaite, CM Tammemagi, DH Moore, EM Ozanne, RA Hiatt, ... International Journal of Cancer 124 (5), 1213-1219, 2009 | 142 | 2009 |
| Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers A comparative effectiveness analysis KP Lowry, JM Lee, CY Kong, PM McMahon, ME Gilmore, JE Cott Chubiz, ... Cancer 118 (8), 2021-2030, 2012 | 126 | 2012 |
| Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines C O'Donoghue, M Eklund, EM Ozanne, LJ Esserman Annals of internal medicine 160 (3), 145-153, 2014 | 111 | 2014 |
| Characterizing the impact of 25 years of DCIS treatment EM Ozanne, Y Shieh, J Barnes, C Bouzan, ES Hwang, LJ Esserman Breast cancer research and treatment 129, 165-173, 2011 | 110 | 2011 |
| Balancing the presentation of information and options in patient decision aids: an updated review P Abhyankar, RJ Volk, J Blumenthal-Barby, P Bravo, A Buchholz, ... BMC medical informatics and decision making 13 (2), 1-10, 2013 | 108 | 2013 |
| Biologic markers determine both the risk and the timing of recurrence in breast cancer LJ Esserman, DH Moore, PJ Tsing, PW Chu, C Yau, E Ozanne, RE Chung, ... Breast cancer research and treatment 129, 607-616, 2011 | 108 | 2011 |
| How to define and measure concordance between patients’ preferences and medical treatments: a systematic review of approaches and recommendations for standardization K Sepucha, EM Ozanne Patient education and counseling 78 (1), 12-23, 2010 | 89 | 2010 |
| Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review T Walsh, PJ Barr, R Thompson, E Ozanne, C O’Neill, G Elwyn Bmj 348, 2014 | 88 | 2014 |
| Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer MD Alvarado, AJ Mohan, LJ Esserman, CC Park, BL Harrison, RJ Howe, ... Annals of surgical oncology 20, 2873-2880, 2013 | 77 | 2013 |
| Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers JM Lee, PM McMahon, CY Kong, DB Kopans, PD Ryan, EM Ozanne, ... Radiology 254 (3), 793-800, 2010 | 77 | 2010 |
| Impact of ductal carcinoma in situ terminology on patient treatment preferences ZB Omer, ES Hwang, LJ Esserman, R Howe, EM Ozanne JAMA internal medicine 173 (19), 1830-1831, 2013 | 76 | 2013 |
| Implementing breast cancer decision aids in community sites: barriers and resources KA Silvia, EM Ozanne, KR Sepucha Health Expectations 11 (1), 46-53, 2008 | 76 | 2008 |
| Current best practice for presenting probabilities in patient decision aids: fundamental principles C Bonner, LJ Trevena, W Gaissmaier, PKJ Han, Y Okan, E Ozanne, ... Medical Decision Making 41 (7), 821-833, 2021 | 68 | 2021 |
| Predictors of households at risk for food insecurity in the United States during the COVID-19 pandemic BN Lauren, ER Silver, AS Faye, AM Rogers, JA Woo-Baidal, EM Ozanne, ... Public health nutrition 24 (12), 3929-3936, 2021 | 68 | 2021 |
| Using Collabo RATE, a brief patient‐reported measure of shared decision making: results from three clinical settings in the United States RC Forcino, PJ Barr, AJ O'Malley, R Arend, MG Castaldo, EM Ozanne, ... Health Expectations 21 (1), 82-89, 2018 | 68 | 2018 |
| Which Risk Model to Use? Clinical Implications of the ACS MRI Screening GuidelinesClinical Implications of the ACS MRI Screening Guidelines EM Ozanne, B Drohan, P Bosinoff, A Semine, M Jellinek, C Cronin, ... Cancer epidemiology, biomarkers & prevention 22 (1), 146-149, 2013 | 68 | 2013 |
Rachel ThompsonThe University of SydneyVerified email at sydney.edu.au
